Instituto Mechnikov

Instituto Mechnikov is a biotechnology company and vaccine manufacturing facility located in Managua, Nicaragua. Established as a joint venture between the St. Petersburg Institute of Vaccines and Sera of Russia and the Nicaraguan Social Security Institute, it serves as a strategic hub for vaccine production in Latin America. The facility primarily focuses on the production of influenza vaccines and has expanded its capabilities to include other immunobiological products, such as COVID-19 vaccines. It operates under Good Manufacturing Practice (GMP) standards to supply high-quality biological products to the Central American and Caribbean regions.